Home/Experimental Diabetes Research/Article Record
Peer-Reviewed Article December 31, 2010

Role of T Cells in Type 2 Diabetic Nephropathy

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: Experimental Diabetes Research
Publisher: Hindawi Publishing Corporation • Egypt • 1687-5214
DOI: https://doi.org/10.1155/2011/514738

Abstract

Type 2 diabetic nephropathy (DN) is the most common cause of end-stage renal disease and is increasingly considered as an inflammatory disease characterized by leukocyte infiltration at every stage of renal involvement. Inflammation and activation of the immune system are closely involved in the pathogenesis of diabetes and its microvascular complications. Macrophage has been well recognized to play an important role in type 2 DN, leukocyte infiltration, and participated in process of DN, as was proposed recently. Th1, Th2, Th17, T reg, and cytotoxic T cells are involved in the development and progression of DN. The purpose of this review is to assemble current information concerning the role of T cells in the development and progression of type 2 DN. Specific emphasis is placed on the potential interaction and contribution of the T cells to renal damage. The therapeutic strategies involving T cells in the treatment of type 2 DN are also reviewed. Improving knowledge of the recognition of T cells as significant pathogenic mediators in DN reinforces the possibility of new potential therapeutic targets translated into future clinical treatments.

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

114
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.